EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of in silico predictions of action potential duration in response to inhibition of IKr and ICaL with new human ex vivo recordings

Yann-Stanislas H M Barral iD, Liudmila Polonchuk, Michael Clerx, David J Gavaghan, Gary R Mirams iD, Ken Wang

PLOS Computational Biology · 2025

DOI: 10.1371/journal.pcbi.1012913 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift PLOS Computational Biology, 2025. Verfasst von Yann-Stanislas H M Barral und 5 weiteren Autor:innen. Beteiligte Einrichtung: Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. Hauptthemen laut MEDLINE: Action Potentials. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During drug development, candidate compounds are extensively tested for proarrhythmic risk and in particular risk of Torsade de Pointes (TdP), as indicated by prolongation of the QT interval. Drugs that inhibit the rapid delayed rectifier K + current ( I Kr ) can prolong the action potential duration (APD) and thereby the QT interval, and so are routinely rejected. However, simultaneous inhibition of the L-type Ca 2 + current ( I CaL ) can mitigate the effect of I Kr inhibition, so that including both effects can improve test specificity. Mathematical models of the action potential (AP) can be used to predict the APD prolongation resulting from a given level of I Kr and I CaL inhibition, but for use in safety-testing their predictive capabilities should first be carefully verified. We present the first systematic comparison between experimental drug-induced APD and predictions by AP models. New experimental data were obtained ex vivo for APD response to I Kr and/or I CaL inhibition by applying 9 compounds at different concentrations to adult human ventricular trabeculae at physiological temperature. Compounds with similar effects on I Kr and I CaL exhibited less APD prolongation compared to selective I Kr inhibitors. We then integrated in vitro IC 50 patch-clamp data for I Kr and I CaL inhibition by the tested compounds into simulations with AP models. Models were assessed against the ex vivo data on their ability to recapitulate drug-induced APD changes observed experimentally. None of the tested AP models reproduced the APD changes observed experimentally across all combinations and degrees of I Kr and/or I CaL inhibition: they matched the data either for selective I Kr inhibitors or for compounds with comparable effects on I Kr and I CaL . This work introduces a new benchmarking framework to assess the predictivity of current and future AP models for APD response to I Kr and/or I CaL inhibition. This is an essential primary step towards an in silico framework that integrates in vitro data for translational clinical cardiac safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Action PotentialsHumansComputer SimulationComputational BiologyModels, CardiovascularTorsades de PointesMale

Autor:innen und Institutionen

  • Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Department of Computer Science, University of Oxford, Oxford, United Kingdom.
  • Centre for Mathematical Medicine and Biology, School of Mathematical Sciences, University of Nottingham, Nottingham, United Kingdom.

ORCID-Profile: Yann-Stanislas H M Barral, Gary R Mirams

Förderung

  • Wellcome Trust

Zitieren

APA

Barral, Y. H. M., Polonchuk, L., Clerx, M., Gavaghan, D. J., Mirams, G. R., & Wang, K. (2025). Comparison of in silico predictions of action potential duration in response to inhibition of IKr and ICaL with new human ex vivo recordings. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1012913

Vancouver

Barral YHM, Polonchuk L, Clerx M, Gavaghan DJ, Mirams GR, Wang K. Comparison of in silico predictions of action potential duration in response to inhibition of IKr and ICaL with new human ex vivo recordings. PLOS Computational Biology. 2025. doi:10.1371/journal.pcbi.1012913

BibTeX
@article{Barral2025,
  author = {Barral, Yann-Stanislas H M and Polonchuk, Liudmila and Clerx, Michael and Gavaghan, David J and Mirams, Gary R and Wang, Ken},
  title = {Comparison of in silico predictions of action potential duration in response to inhibition of IKr and ICaL with new human ex vivo recordings},
  journal = {PLOS Computational Biology},
  year = {2025},
  doi = {10.1371/journal.pcbi.1012913}
}
Kostenlos starten →